H.R. 6486, The Drug Testing Integrity Act of 2008

• This item is from the 110th Congress (2007-2008) and is no longer current. Comments, voting, and wiki editing have been disabled, and the cost/savings estimate has been frozen.

Version saved on October 16, 2008, 19:35:36, by webmaster:

H.R. 6486 would prohibit the manufacture, marketing, sale, or shipment in interstate commerce of products designed to assist in defrauding a drug test.

Detailed Summary

Drug Testing Integrity Act of 2008 - Makes it unlawful to knowingly manufacture, market, sell, ship, or otherwise provide to another individual any product with the intent to assist such individual to use such product to defraud a drug test. Defines "defraud a drug test" to mean to: (1) submit a substance that purports to be from an individual other than its actual source, or purports to have been excreted or collected other than when it was actually excreted or collected; or (2) engage in any other conduct with the intent to produce a false or misleading outcome of a test for the presence of a controlled substance.

Grants the Federal Trade Commission (FTC) enforcement powers as a violation of an unfair or deceptive act or practice.

Status of the Legislation

Latest Major Action: 7/14/2008: Referred to House committee. Status: Referred to the House Committee on Energy and Commerce.

Points in Favor

(Log in to edit the wiki and be the first to show why the bill should pass!)

Points Against

(Log in to edit the wiki and be the first to show why the bill should not pass!)

« Return to Revision History.